bile duct cancer
Showing 1 - 25 of 69
Ampullary Cancer, Bile Duct Cancer, Pancreas Cancer Trial in Zhanjiang (Modified Blumgart Anastomosis in LPD, conventional
Enrolling by invitation
- Ampullary Cancer
- +3 more
- Modified Blumgart Anastomosis in LPD
- conventional Blumgart anastomosis in LPD
-
Zhanjiang, Guangdong, ChinaThe Affiliated Hospital of Guangdong Medical University
Oct 7, 2023
Biliary Tract Carcinoma, Cholangiocarcinoma, Bile Duct Cancer Trial in Madison (Gemcitabine, Cisplatin, Zimberelimab)
Not yet recruiting
- Biliary Tract Carcinoma
- +2 more
- Gemcitabine
- +3 more
-
Madison, WisconsinUniversity of Wisconsin
Sep 15, 2023
Colorectal Cancer, Esophagus Cancer, Gastric Cancer Trial in Hangzhou (CEA-targeted CAR-T cells)
Recruiting
- Colorectal Cancer
- +6 more
- CEA-targeted CAR-T cells
-
Hangzhou, Zhejiang, China
- +1 more
Sep 18, 2023
ful Mutations in Solid Tumor Characterized by Next Generation
Recruiting
- Solid Tumor
- +13 more
-
Aviano, Pordonone, ItalyIRCCS, Centro di Riferimento Oncologico (CRO) di Aviano
Sep 8, 2023
Bile Duct Cancer Trial (envolizumab , sovalteinib)
Not yet recruiting
- Bile Duct Cancer
- envolizumab , sovalteinib
- (no location specified)
Jun 20, 2023
Biliary Cancer, Bile Duct Cancer, Cancer of the Bile Duct Trial run by the National Cancer Institute (NCI) (oxaliplatin,
Not yet recruiting
- Biliary Cancer
- +2 more
- oxaliplatin
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
May 13, 2023
Melanoma, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in Australia (AI-061)
Not yet recruiting
- Melanoma
- +16 more
-
Darlinghurst, New South Wales, Australia
- +3 more
May 12, 2023
Looking At Bile Duct Cancer Patient Experience Patterns in
Not yet recruiting
- Bile Duct Cancer
- (no location specified)
Jan 20, 2023
Bile Duct Cancer, Cholangiocarcinoma, Cholangiocarcinoma Non-resectable Trial in Boston (Gemcitabine, Cisplatin, Durvalumab)
Not yet recruiting
- Bile Duct Cancer
- +4 more
- Gemcitabine
- +3 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 23, 2023
Metastatic Colorectal Cancer (Mcrc), Intrahepatic Cholangiocarcinoma (Icc), Colorectal Cancer Trial run by the National Cancer
Recruiting
- Metastatic Colorectal Cancer (Mcrc)
- +7 more
- Floxuridine
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)
Recruiting
- Advanced Cancer
- +24 more
- pembrolizumab
-
Los Angeles, California
- +21 more
Jan 18, 2023
Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)
Recruiting
- Minimal Residual Disease
- +11 more
- ELI-002 2P
-
Duarte, California
- +10 more
Jan 18, 2023
Recurrence After Whipple's (RAW) Study
Active, not recruiting
- Pancreatic Cancer
- +13 more
- Pancreaticoduodenectomy
-
Clayton, Victoria, Australia
- +28 more
Jan 13, 2023
Peritoneal Carcinomatosis, Peritoneal Metastases, Colorectal Cancer Trial in Ghent (PIPAC with Nal-IRI)
Recruiting
- Peritoneal Carcinomatosis
- +7 more
- PIPAC with Nal-IRI
-
Ghent, East-Flanders, BelgiumUZ Ghent
Dec 28, 2022
Liver and Biliary Cancer Patients Treated With PD-1 Combination
Active, not recruiting
- Hepatocellular Carcinoma
- Bile Duct Cancer
- [68Ga]FAPI PET/CT and [18F]FDG PET/CT
-
Beijing, ChinaDepartment of Nuclear Medicine, Peking Union Medical College Hop
Dec 14, 2022
Cholangiocarcinoma, Bile Duct Cancer Trial in Toronto (Trifluridine/Tipiracil)
Terminated
- Cholangiocarcinoma
- Bile Duct Cancer
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Nov 28, 2022
Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)
Recruiting
- Adenocarcinoma
- +75 more
- Biomarker Testing (L)
- +2 more
-
Idaho Falls, Idaho
- +1 more
Oct 18, 2022
Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,
Active, not recruiting
- Breast Cancer
- +10 more
- INT230-6
- +2 more
-
Los Angeles, California
- +7 more
Jun 21, 2022
Inoperable Disease, Bile Duct Cancer Trial in Cluj-Napoca (Endoscopic ultrasound with fine needle biopsy)
Recruiting
- Inoperable Disease
- Bile Duct Cancer
- Endoscopic ultrasound with fine needle biopsy
-
Cluj-Napoca, Cluj, RomaniaIRGH "O. Fodor"
Jun 14, 2022
Biliary Tract Tumors, Liver Cancer, Hepatocellular Carcinoma Trial run by the NCI (Durvalumab, Tremelimumab, Trans-arterial
Active, not recruiting
- Biliary Tract Neoplasms
- +4 more
- Durvalumab
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Mar 1, 2022
Bile Duct Cancer, Intrahepatic Cholangiocarcinoma Trial in Durham, Columbus, Memphis (Melphalan/HDS, Cisplatin and Gemcitabine)
Active, not recruiting
- Bile Duct Cancer
- Intrahepatic Cholangiocarcinoma
- Melphalan/HDS
- Cisplatin and Gemcitabine
-
Durham, North Carolina
- +2 more
Mar 23, 2022
Adverse Drug Event, Colon Cancer, Breast Cancer Trial in Odense (DPYD genotype)
Recruiting
- Adverse Drug Event
- +7 more
- DPYD genotype
-
Odense, Syddanmark, DenmarkThe Department of Oncology at University of southern denmark
Mar 3, 2022
Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States
Recruiting
- Pancreatic Cancer
- +49 more
-
Colorado Springs, Colorado
- +80 more
Feb 22, 2022